FDA concerned over foreign trials data
As more companies outsource expensive human clinical trials to lower-cost foreign sites, the FDA says it is confronting "huge" challenges in the safety and effectiveness of data that come back to the US for review.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.